Shares of Synthetic Biology Hopeful Zymergen Plunge as CEO Departs
Zymergen
disclosed late Tuesday that its CEO Josh Hoffman was leaving after some customers had problems implementing the companys main product. The shares plummeted more than 68% in after-hours trading following the announcement.The company, which uses…
